At Avanir Pharmaceuticals, Inc., we focus on the research, development, and commercialization of novel medical and pharmaceutical treatments for people with central nervous system disorders. That focus, along with the deep-seated passion of our people, fuels the development of innovative medical solutions.
PRESIDENT & CEO
Wa’el Hashad joined Avanir as President & CEO in July 2017. Prior to working for Avanir, Wa’el served as Executive Vice President and Chief Commercial Officer of Seres Therapeutics.